Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Enzinger

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Cancer Investigation|June 17, 2006
A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinomaMatthew H Kulke, Alona Muzikansky, Jeffrey Clark, et al.
Annals of Surgery|April 17, 2007
Impact of hospital volume on recurrence and survival after surgery for gastric cancerPeter C Enzinger, Jacqueline K Benedetti, Jeffrey A Meyerhardt, et al.
Annals of Nuclear Medicine|January 15, 2018
Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic responseVictor H Gerbaudo, Joseph H Killoran, Chun K Kim, et al.
Cancer Investigation|July 1, 2006
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagusMatthew H Kulke, Bingyan Wu, Jeffrey W Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Keith Stuart, Peter C Enzinger, et al.
Cancer|August 27, 2004
A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsMatthew H Kulke, Haesook Kim, Jeffrey W Clark, et al.
Clinical Colorectal Cancer|June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancerJeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.
Digestive Diseases and Sciences|July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Bingyan Wu, David P Ryan, et al.
American Journal of Clinical Oncology|February 8, 2006
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum, Bingyan Wu, Jeffrey W Clark, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Secondary Esophageal Cancer After Hematopoietic Stem Cell Transplant: An Institutional Case SeriesAnupama Singh, Miles McAllister, Ashley L Deeb, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Cancer Investigation|June 17, 2006
A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinomaMatthew H Kulke, Alona Muzikansky, Jeffrey Clark, et al.
Annals of Surgery|April 17, 2007
Impact of hospital volume on recurrence and survival after surgery for gastric cancerPeter C Enzinger, Jacqueline K Benedetti, Jeffrey A Meyerhardt, et al.
Annals of Nuclear Medicine|January 15, 2018
Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic responseVictor H Gerbaudo, Joseph H Killoran, Chun K Kim, et al.
Cancer Investigation|July 1, 2006
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagusMatthew H Kulke, Bingyan Wu, Jeffrey W Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Keith Stuart, Peter C Enzinger, et al.
Cancer|August 27, 2004
A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsMatthew H Kulke, Haesook Kim, Jeffrey W Clark, et al.
Clinical Colorectal Cancer|June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancerJeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.
Digestive Diseases and Sciences|July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Bingyan Wu, David P Ryan, et al.
American Journal of Clinical Oncology|February 8, 2006
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum, Bingyan Wu, Jeffrey W Clark, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Secondary Esophageal Cancer After Hematopoietic Stem Cell Transplant: An Institutional Case SeriesAnupama Singh, Miles McAllister, Ashley L Deeb, et al.
Pageof 10